Delivery Order SPE2DB22D9239-SPE2DB23FDH30
- Not listed
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business. The order is for the supply of a pharmaceutical product, JAKAFI 10 MG TABLET 60S, with a potential value of $11,840.66 and a completion date of January 19, 2024. DMS Pharmaceutical Group is a leading pharmaceutical wholesaler that provides a wide range of brand and generic prescription and over-the-counter drug supplies to the federal government,...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business. The order is for the supply of a pharmaceutical product, JAKAFI 15 MG TABLET 60S, with a potential value of $11,773.87 and a completion date of January 9, 2024. DMS Pharmaceutical Group Inc. is a leading pharmaceutical wholesaler that provides a wide range of brand and generic prescription and over-the-counter drug supplies to the federal...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business. The contract has a potential value of $11,840.66 and a completion date of January 23, 2024. It is for the delivery of the pharmaceutical product JAKAFI 10 MG TABLET 60S. DMS Pharmaceutical Group Inc. is a leading pharmaceutical wholesaler that provides a wide range of brand and generic prescription and over-the-counter drug supplies to the...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business, to provide the pharmaceutical item JAKAFI 5 MG TABLET 60S. The $106,198.92 order is part of a larger indefinite delivery contract between DMS Pharmaceutical Group and DLA to supply a variety of pharmaceutical and medical products in support of military treatment facilities worldwide. This delivery order has a completion date of July 12, 2022. DMS...
- This is a $24,179.58 firm fixed-price delivery order awarded to DMS Pharmaceutical Group Inc., a woman-owned small business, by the Defense Logistics Agency (DLA) to provide JAKAFI 20 MG TABLET 60S. The delivery order has an ultimate completion date of June 26, 2025. DMS Pharmaceutical Group Inc. is a pharmaceutical wholesaler that specializes in supplying a comprehensive range of pharmaceutical products, including branded and generic prescription drugs, over-the-counter medications,...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business. The order is for the supply of JAKAFI 10 MG TABLET 60S, a pharmaceutical product. The contract has a potential value of $11,840.66 and a completion date of January 9, 2024. DMS Pharmaceutical Group is a leading pharmaceutical wholesaler that provides a range of brand and generic prescription and over-the-counter drug supplies to the federal...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The $12,146.79 contract is for the delivery of JAKAFI 5 MG TABLET 60S, a specialized prescription medication, with a completion date of February 6, 2025. DMS Pharmaceutical Group holds a larger $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which enables the DLA to issue firm...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a for-profit, woman-owned small business. The $32,842.02 contract is to deliver JAKAFI 5 MG TABLET 60S to support the operations of DLA Troop Support Medical facilities. DMS Pharmaceutical Group Inc. is a leading pharmaceutical wholesaler that provides brand and generic prescription drugs and over-the-counter medical supplies to the federal government, primarily the...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to DMS Pharmaceutical Group Inc., a woman-owned small business. The contract is for the delivery of the pharmaceutical product JAKAFI 5 MG TABLET 60S to the agency. The total potential value of the contract is $47,399.24, and the period of performance runs through January 8, 2024. DMS Pharmaceutical Group is a leading pharmaceutical wholesaler that provides a wide range of brand and...
- The Defense Logistics Agency awarded a firm fixed price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business, to provide 4563200038 - JAKAFI 15 MG TABLET 60S. The order, with a potential value of $10,937.15, is scheduled for completion by January 2, 2024. DMS Pharmaceutical Group Inc. is a leading pharmaceutical wholesaler that provides a wide range of brand and generic prescription and over-the-counter drugs to federal agencies, primarily the Department of Defense,...
- SPE2DB22D9239Indefinite Delivery Contract
- SPE2DB22D9239-SPE2DB23FDH30Delivery Order
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business. The order is for the pharmaceutical product JAKAFI 5 MG TABLET 60S, with a potential value of $117,910.06 and a completion date of March 22, 2023. DMS Pharmaceutical Group is a leading pharmaceutical wholesaler that provides a wide range of brand and generic prescription and over-the-counter drug supplies to the federal government, primarily the Department of Defense, through various indefinite delivery contracts and delivery orders. This specific order is issued under a larger DLA contract vehicle to procure necessary pharmaceutical items and medical products on a firm fixed price basis to fulfill the routine needs of military treatment centers supported by DLA worldwide. The contract does not have a set-aside designation.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $117.9k | 3/21/23 |